Literature DB >> 15596610

Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease.

Ekaterina Rogaeva1, Janel Johnson, Anthony E Lang, Cindy Gulick, Katrina Gwinn-Hardy, Toshitaka Kawarai, Christine Sato, Angharad Morgan, John Werner, Robert Nussbaum, Agnes Petit, Michael S Okun, Aideen McInerney, Ronald Mandel, Justus L Groen, Hubert H Fernandez, Ron Postuma, Kelly D Foote, Shabnam Salehi-Rad, Yan Liang, Sharon Reimsnider, Anurag Tandon, John Hardy, Peter St George-Hyslop, Andrew B Singleton.   

Abstract

BACKGROUND: Mutations in the PTEN-induced kinase (PINK1) gene located within the PARK6 locus on chromosome 1p35-p36 have recently been identified in patients with recessive early-onset Parkinson disease.
OBJECTIVE: To assess the prevalence of PINK1 mutations within a series of early- and late-onset Parkinson disease patients living in North America.
DESIGN: All coding exons of the PINK1 gene were sequenced in a series of 289 Parkinson disease patients and 80 neurologically normal control subjects; the mutation frequencies were evaluated in additional controls (100 white and 50 Filipino subjects).
RESULTS: We identified 27 variants, including the first reported compound heterozygous mutation (Glu240Lys and Leu489Pro) and a homozygous Leu347Pro mutation in 2 unrelated young-onset Parkinson disease patients.
CONCLUSION: Autosomal recessive mutations in PINK1 are a rare cause of young-onset Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15596610     DOI: 10.1001/archneur.61.12.1898

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  51 in total

Review 1.  Genetics of Parkinson's disease.

Authors:  Christine Klein; Ana Westenberger
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  PINK1 mutation heterozygosity and the risk of Parkinson's disease.

Authors:  M Toft; R Myhre; L Pielsticker; L R White; J O Aasly; M J Farrer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

3.  Mutation analysis of Parkin, PINK1 and DJ-1 genes in Chinese patients with sporadic early onset parkinsonism.

Authors:  Ji-feng Guo; Xue-wei Zhang; Li-luo Nie; Hai-nan Zhang; Bin Liao; Jing Li; Lei Wang; Xin-xiang Yan; Bei-sha Tang
Journal:  J Neurol       Date:  2010-02-10       Impact factor: 4.849

Review 4.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

5.  Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson's Disease.

Authors:  Rebecca A Johnson; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

6.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

7.  Analysis of exon dosage using MLPA in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Debbie Lombard; Rene Veikondis; Jonathan Carr; Soraya Bardien
Journal:  Neurogenetics       Date:  2009-12-15       Impact factor: 2.660

Review 8.  Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.

Authors:  Pradip K Kamat; Anuradha Kalani; Philip Kyles; Suresh C Tyagi; Neetu Tyagi
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

9.  Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation.

Authors:  Jügen Prestel; Klaus Gempel; Till-Karsten Hauser; Katherine Schweitzer; Holger Prokisch; Uwe Ahting; Dirk Freudenstein; Eva Bueltmann; Thomas Naegele; Daniela Berg; Thomas Klopstock; Thomas Gasser
Journal:  J Neurol       Date:  2008-02-21       Impact factor: 4.849

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.